Recombinant S100P antibody (C-Term)

Catalog No. ABIN7877473

The Mouse Monoclonal anti-S100P antibody (Clone rS100P-9254) (ABIN7877473) specifically detects S100P in IHC (p). The antibody is reactive with Human samples.

Quick Overview for Recombinant S100P antibody (C-Term) (ABIN7877473)

Target: S100P (S100 Calcium Binding Protein P (S100P))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This S100P antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: RS100P-9254

Product Details anti-S100P Antibody

Binding Specificity: C-Term

Purpose: Recombinant S100P Antibody / MIG9 (azide and preservative free)

Purification: Protein A/G affinity

Immunogen: A recombinant fragment corresponding to the C-terminus of human S100P/MIG9 protein was used as the immunogen for the recombinant S100P antibody.

Isotype: IgG2b, kappa

Application Details

Application Notes: Optimal dilution of the recombinant S100P antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: -20 °C

Storage Comment: Aliquot the recombinant S100P antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for S100P

Target: S100P (S100 Calcium Binding Protein P (S100P))

Alternative Name: S100P

Background: S100P is a 95-amino-acid protein and a member of the S100 family. S100P has been shown to mediate tumor growth, metastasis and invasion through the binding of Ca2+ ions, receptor for advanced glycation end products, cytoskeletal protein ezrin, calcyclin-binding protein/Siah-1-interacting protein and cathepsin D. S100P highly expressed in human placenta, gastrointestinal tract, and esophageal mucosa, but always negative in pancreas and liver. Overexpression of S100P has been detected in several cancers such as breast, colon, prostate, pancreatic and lung carcinomas, and the protein has been functionally implicated in carcinogenic processes. S100P could potentially serve as diagnostic marker, prognostic/predictive indicator and therapy target for different carcinomas.

UniProt: P25815

Pathways: Regulation of Muscle Cell Differentiation, Toll-Like Receptors Cascades, S100 Proteins